Publications by authors named "Wanda Depinto"

Claim this Profile
P
Preclinical biomarkers for a cyclin-dependent kinase inhibitor translate to candidate pharmacodynamic biomarkers in phase I patients.
Windy Berkofsky-Fessler, Tri Q Nguyen, Paul Delmar, Juliette Molnos, Charu Kanwal, Wanda DePinto

Mol Cancer Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity.
Xin-Jie Chu, Wanda DePinto, David Bartkovitz, Sung-Sau So, Binh T Vu

J Med Chem· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials.
Wanda DePinto, Xin-Jie Chu, Xuefeng Yin, Melissa Smith, Kathryn Packman

Mol Cancer Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of S/G2 phase CDK4 reduces mitotic fidelity.
Andrew Burgess, Matthew Wigan, Nichole Giles, Wanda Depinto, Paul Gillespie

J Biol Chem· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new series of potent oxindole inhibitors of CDK2.
Kin-Chun Luk, Mary Ellen Simcox, Andy Schutt, Karen Rowan, Thelma Thompson, Wanda DePinto

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3,5,6-Trisubstituted naphthostyrils as CDK2 inhibitors.
Jin-Jun Liu, Apostolos Dermatakis, Christine Lukacs, Fred Konzelmann, Yi Chen, Wanda Depinto

Bioorg Med Chem Lett· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of potent oxindole CDK2 inhibitors.
Apos Dermatakis, Kin Chun Luk, Wanda DePinto

Bioorg Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis